Abstract: The invention relates to the combination of a light ray with a cytochrome C oxydase substrate particularly for improving the appearance of the skin and/or the hair. The invention more particularly relates to a method for a cosmetic treatment particularly for improving the appearance of the skin and/or the hair that comprises the simultaneous and/or sequential administration of a) at least one cytochrome C oxydase substrate and/or at least one agent increasing the expression of said substrate; and b) at least one light radiation having at least one predominant wavelength that activates the cytochrome C oxydase. More particularly, said light radiation has at least one predominant wavelength activating the cytochrome C oxydase, that ranges from 550 to 1000 nm, in particular from 550 to 800 nm, preferably from 620 to 700 nm, and more preferably from 640 to 680 nm; the method comprises applying a dose preferably ranging from 0.01 to 200 J/cm2, preferably from 0.

Abstract: An efficient and non-iterative 3D post processing method and system is proposed for mosquito noise reduction, block localization and correction in DCT block-based decoded images. The 3D post processing is based on a simple classification that segments a picture in multiple regions such as Edge, Near Edge, Flat, Near Flat and Texture regions. The proposed technique comprises also an efficient and shape adaptive local power estimation for equivalent additive noise and provides simple noise power weighting for each above cited region. Temporal filtering configurations using Minimum Noise Variance Criterion are proposed for reducing temporally varying coding artifacts. A Minimum Mean Square Error or Minimum Mean Square Error-like noise reduction with robust and effective shape adaptive windowing is utilized for smoothing mosquito and/or random noise for the whole image, particularly for Edge regions.

Abstract: The present invention relates more specifically to the use of a source of green light for activating L-amino acid oxidase in the presence of at least one substrate of this enzyme in order to stimulate the energy metabolism of the cells of the skin, to stimulate their replacement and thus to improve the appearance of the skin and hair, in particular to prevent and/or treat cutaneous signs of ageing of the skin and hair. The invention also relates to a composition comprising at least one substrate of the enzyme and at least one substrate capable of emitting green light, to a kit comprising a green light device and the composition comprising at least one substrate of the said enzyme and to a cosmetic method employing the compositions or kits according to the invention.

Abstract: In an example, one or more cryptographic keys may be associated with a group. Any member of the group may use the key to encrypt and decrypt information, thereby allowing members of the group to share encrypted information. Domain controllers (DCs) maintain copies of the group's keys. The DCs may synchronize with each other, so that each DC may have a copy of the group's keys. Keys may have expiration dates, and any client connected to a DC may generate a new key when a key is nearing expiration. The various clients may create new keys at differing amounts of time before expiration on various DCs. DCs that store keys early thus may have time to propagate the newly-created keys through synchronization before other DCs are requested to store keys created by other clients. In this way, the creation of an excessive number of new keys may be avoided.

Abstract: The invention relates to composite material containing a proportion of wood and a proportion of crosslinked melamine resins, which is characterized in that the crosslinked melamine resins are formed from melamine resins that are, in essence, linearly synthesized and have a shear-dependent viscosity. The invention also relates to a method for producing the composite materials and to the use thereof.

Abstract: The present description discloses a method for resizing an input image having input pixels. The method comprises segmenting the input made into region types by assigning one of the region types to each one of the input pixels; and interpolating the input image according to the region type assigned to each one of the input pixels to produce a resized image having interpolated pixels.

Abstract: A two-stage treatment process suitable for the permanent deformation and/or shaping of keratinous substances and, in particular, the hair includes the application of a reducing composition containing, in addition to a reducing agent, an organic absorbing agent followed, after an optional rinsing, by the application of a neutralizing composition and by the rinsing of the keratinous substances thus treated.

Abstract: The invention relates to composite materials, comprising plastics and wood, with 55 to 90 mass % of wood in the form of sawdust, wood fibres, and/or wood chippings and 45 to 10 mass % of partly crosslinked melamine resin ethers or mixtures of partly crosslinked thermoplastics and crosslinked melamine resin ethers, whereby the plastics in the composite materials can be in the form of a foam. Said materials can be produced by homogenization of the components in the extruder, pre-impregnation of wood with melamine resins in the screw mixer and subsequent homogenization of the components in the extruder, or by a sinter method, each followed by a subsequent moulding to give the composite material. The composite materials are suitable for application in building and in sport and leisure applications.

Abstract: The present invention relates to methods of use 1,1- and 1,2-bisphosphonate compounds to modulate apolipoprotein E levels and use of such compounds in therapy, including cardiovascular and neurological disease states.

Abstract: The invention concerns a method for the permanent setting of keratin fibres and in particular hair, characterised in that it consists in: applying on the keratin fibres a composition reducing keratin, with adhesive capacity less than 15 g and a viscosity ranging between 0 and 2500 mpa's at a laminar flow rate of 100 s?1 and setting them; after sufficient setting time for reducing keratin, applying an oxidising composition, without intermediate rinsing of the fibres; rinsing after sufficient time for fixing the set fibres and reduced fibres in permanent setting; rinsing with water.

Abstract: The present invention relates to the novel hydroxyphosphonates and phosphonophosphates and the methods of their use to modulate apolipoprotein E levels and the use of such compounds in therapy, including cardiovascular and neurological disease states.

Abstract: The invention provides a method for increasing apolipoprotein E (ApoE) in plasma and in tissues of a mammal by using a combination of an ApoE increasing amount of an activator of the orphan nuclear receptor FXR and an ApoE increasing amount of an activator of the orphan nuclear receptor LXR?. Also provided is the use of a combination of an ApoE increasing amount of a FXR activator and of an ApoE increasing amount of a LXR? activator, for the manufacture of a medicament for increasing ApoE in plasma and in tissues of a mammal.

Abstract: The present invention relates to methods of use of phosphonate-phosphates and diphosphonates to modulate apolipoprotein E levels and the use of such compounds in therapy, including cardiovascular and neurological disease states.

Abstract: The present invention relates to novel ?-substituted-?-aminoethylphosphonate and ?-substituted-?-aminovinylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and very low density lipoproteins) and for lowering plasma levels of total cholesterol.

Abstract: The present invention relates to novel ?-substituted arylalkylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and very low density lipoproteins) and for lowering plasma levels of total cholesterol.

Abstract: The present invention relates to novel ?-substituted heteroarylalkylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and very low density lipoproteins) and for lowering plasma levels of total cholesterol.

Abstract: A tooth whitening product is provided. The tooth whitening product has a backing layer and a tooth whitening composition. The tooth whitening composition includes first and second polymers, water, and a tooth whitening agent. The first polymer is a water soluble polymer and the second polymer is polyvinyl alcohol.

Abstract: The present invention relates to methods of use of aminodiphosphonate to modulate apolipoprotein E levels and the use of such compounds in therapy, including cardiovascular and neurological disease states.

Abstract: A tooth whitening product is provided. The tooth whitening product has a backing layer and a tooth whitening composition. The tooth whitening composition includes first and second water soluble polymers, water, and a tooth whitening agent, wherein the first water soluble polymer is polyethelene oxide and the second water soluble polymer is polyvinyl alcohol.

Abstract: A tooth whitening product is provided. The tooth whitening product has a backing layer and a tooth whitening composition. The tooth whitening composition includes first and second water soluble polymers, water, and a tooth whitening agent, wherein the first water soluble polymer is polyethelene oxide and the second water soluble polymer is polyvinyl alcohol.